Resumen de Adaptation of the chemotherapy prescription for breast cancer in a tertiary hospital. Impact on survival
Ana María Alañón Pardo, Ruth Ubago Pérez, Miguel Angel Calleja Hernández, P. Araque Arroyo, Bárbara Cancela Díez
Objective: To analyze the degree or adaptation in the chemotherapy prescriptions for breast cancer therapy to the Integrated Care Process (ICP) and the Spanish Society of Gynecology and Obstetrics (SEGO) protocols; identify the causes of no-adaptation; and assess the survival rate according to the adaptation. Method: A retrospective observational study was conducted on patients who were diagnosed with breast cancer in 2006 and treated with chemotherapy since that year. A follow-up was performed until December 2010. Results: 131 patients who received a total of 189 treatments were included. The overall adaptation to the ICP was 27% and 21.7% to the SEGO. The most frequent causes of no adaptation were related to the indication and the used regimen. The five year survival rate in the groups of «no-adaptation» to both protocols was higher than the calculated for the groups of «yes- adaptation», with statistically significant differences in both cases. Conclusions: The degree of adaptation to both protocols is low and does not seem to be directly related to an improvement in the survival rate
